-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
6-Chloroimidazo[1,2-b]pyridazine-2-carboxylic acid is an important intermediate in the production of various pharmaceuticals, agrochemicals, and other chemical products.
In the chemical industry, the synthesis of this compound is a complex multi-step process that involves several different reactions and purifications.
One of the most common methods for the synthesis of 6-chloroimidazo[1,2-b]pyridazine-2-carboxylic acid involves the following steps:
- Preparation of the starting material: 2-amino-5-bromopyridine
- Bromination of 2-amino-5-pyridine
- Reduction of the bromine substituent to a methyl group
- Condensation of the methylated compound with another methylated compound to form a new ring
- Halogenation of the new ring to introduce the chlorine atom
The first step in the synthesis of 6-chloroimidazo[1,2-b]pyridazine-2-carboxylic acid is the preparation of 2-amino-5-bromopyridine, which is a starting material for the synthesis of the final product.
This compound can be synthesized through several different methods, including the reaction of 2-amino-5-pyridine with hydrobromic acid or the reaction of 2-amino-5-pyridine with bromine in the presence of an acid catalyst.
The second step in the synthesis of 6-chloroimidazo[1,2-b]pyridazine-2-carboxylic acid is the bromination of 2-amino-5-pyridine.
This is typically accomplished through the reaction of 2-amino-5-pyridine with bromine in the presence of a solvent, such as carbon tetrachloride or 1,2-dichloroethane.
The reaction is typically carried out under anhydrous conditions and with the aid of a catalyst, such as ferric chloride or aluminum chloride.
In the third step of the synthesis of 6-chloroimidazo[1,2-b]pyridazine-2-carboxylic acid, the bromine substituent on the 2-amino-5-pyridine is reduced to a methyl group.
This is typically accomplished through the reduction of the bromine substituent using a reducing agent, such as lithium aluminum hydride or hydrogen in the presence of a solvent, such as acetonitrile or ethanol.
In the fourth step of the synthesis of 6-chloroimidazo[1,2-b]pyridazine-2-carboxylic acid, the methylated compound from the third step is condensed with another methylated compound to form a new ring.
This step is typically accomplished through the reaction of the methylated compound with another methylated compound in the presence of a solvent and with the aid of a catalyst, such as p-toluenesulfonic acid or dodecylbenzenesulfonic acid.
Finally, in the fifth step of the synthesis of 6-chloroimidazo[1,2-b]pyridazine-2-carboxylic acid, the new ring formed in the fourth step is halogenated to introduce the chlorine atom.
This is typically accomplished through the reaction of the new ring with chlorine in the presence of a solvent, such as dichloromethane, and with the aid of a catalyst, such as thionyl chloride or phosphorus trichloride.
Overall, the synthesis of